These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 38669532
1. Impaired Glymphatic Flow on Diffusion Tensor MRI as a Marker of Neurodegeneration in Alzheimer's Disease: Correlation with Gray Matter Volume Loss and Cognitive Decline Independent of Cerebral Amyloid Deposition. Kim M, Song YS, Han K, Bae YJ, Han JW, Kim KW. J Alzheimers Dis; 2024; 99(1):279-290. PubMed ID: 38669532 [Abstract] [Full Text] [Related]
2. Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease. Huang SY, Zhang YR, Guo Y, Du J, Ren P, Wu BS, Feng JF, Alzheimer's Disease Neuroimaging Initiative, Cheng W, Yu JT. Alzheimers Dement; 2024 May; 20(5):3251-3269. PubMed ID: 38501315 [Abstract] [Full Text] [Related]
3. PET/MRI multimodality imaging to evaluate changes in glymphatic system function and biomarkers of Alzheimer's disease. Okazawa H, Nogami M, Ishida S, Makino A, Mori T, Kiyono Y, Ikawa M. Sci Rep; 2024 May 29; 14(1):12310. PubMed ID: 38811627 [Abstract] [Full Text] [Related]
4. Glymphatic system impairment in Alzheimer's disease: associations with perivascular space volume and cognitive function. Zhang X, Wang Y, Jiao B, Wang Z, Shi J, Zhang Y, Bai X, Li Z, Li S, Bai R, Sui B. Eur Radiol; 2024 Feb 29; 34(2):1314-1323. PubMed ID: 37610441 [Abstract] [Full Text] [Related]
5. The relationship between amyloid pathology, cerebral small vessel disease, glymphatic dysfunction, and cognition: a study based on Alzheimer's disease continuum participants. Hong H, Hong L, Luo X, Zeng Q, Li K, Wang S, Jiaerken Y, Zhang R, Yu X, Zhang Y, Lei C, Liu Z, Chen Y, Huang P, Zhang M, Alzheimer’s Disease Neuroimaging Initiative (ADNI). Alzheimers Res Ther; 2024 Feb 20; 16(1):43. PubMed ID: 38378607 [Abstract] [Full Text] [Related]
6. Relationships Between the Deposition of Amyloid-β and Tau Protein and Glymphatic System Activity in Alzheimer's Disease: Diffusion Tensor Image Study. Ota M, Sato N, Nakaya M, Shigemoto Y, Kimura Y, Chiba E, Yokoi Y, Tsukamoto T, Matsuda H. J Alzheimers Dis; 2022 Feb 20; 90(1):295-303. PubMed ID: 36120782 [Abstract] [Full Text] [Related]
7. Evaluation of glymphatic system activity by diffusion tensor image analysis along the perivascular space (DTI-ALPS) in dementia patients. Liang T, Chang F, Huang Z, Peng D, Zhou X, Liu W. Br J Radiol; 2023 Jun 01; 96(1146):20220315. PubMed ID: 37066824 [Abstract] [Full Text] [Related]
8. Gray matter reserve determines glymphatic system function in young-onset Alzheimer's disease: Evidenced by DTI-ALPS and compared with age-matched controls. Chang HI, Huang CW, Hsu SW, Huang SH, Lin KJ, Ho TY, Ma MC, Hsiao WC, Chang CC. Psychiatry Clin Neurosci; 2023 Jul 01; 77(7):401-409. PubMed ID: 37097074 [Abstract] [Full Text] [Related]
9. A "glympse" into neurodegeneration: Diffusion MRI and cerebrospinal fluid aquaporin-4 for the assessment of glymphatic system in Alzheimer's disease and other dementias. Sacchi L, D'Agata F, Campisi C, Arcaro M, Carandini T, Örzsik B, Dal Maschio VP, Fenoglio C, Pietroboni AM, Ghezzi L, Serpente M, Pintus M, Conte G, Triulzi F, Lopiano L, Galimberti D, Cercignani M, Bozzali M, Arighi A. Hum Brain Mapp; 2024 Aug 15; 45(12):e26805. PubMed ID: 39185685 [Abstract] [Full Text] [Related]
10. The Association of Metabolic Brain MRI, Amyloid PET, and Clinical Factors: A Study of Alzheimer's Disease and Normal Controls From the Open Access Series of Imaging Studies Dataset. Matsushita S, Tatekawa H, Ueda D, Takita H, Horiuchi D, Tsukamoto T, Shimono T, Miki Y. J Magn Reson Imaging; 2024 Apr 15; 59(4):1341-1348. PubMed ID: 37424114 [Abstract] [Full Text] [Related]
11. Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer's disease cases. Taoka T, Masutani Y, Kawai H, Nakane T, Matsuoka K, Yasuno F, Kishimoto T, Naganawa S. Jpn J Radiol; 2017 Apr 15; 35(4):172-178. PubMed ID: 28197821 [Abstract] [Full Text] [Related]
12. Assessment of the DTI-ALPS Parameter Along the Perivascular Space in Older Adults at Risk of Dementia. Steward CE, Venkatraman VK, Lui E, Malpas CB, Ellis KA, Cyarto EV, Vivash L, O'Brien TJ, Velakoulis D, Ames D, Masters CL, Lautenschlager NT, Bammer R, Desmond PM. J Neuroimaging; 2021 May 15; 31(3):569-578. PubMed ID: 33556226 [Abstract] [Full Text] [Related]
13. Enlarged choroid plexus in relapsing-remitting multiple sclerosis may lead to brain structural changes through the glymphatic impairment. Xie Y, Zhu H, Yao Y, Liu C, Wu S, Zhang Y, Zhu W. Mult Scler Relat Disord; 2024 May 15; 85():105550. PubMed ID: 38493535 [Abstract] [Full Text] [Related]
14. Association of MRI Indices of Glymphatic System With Amyloid Deposition and Cognition in Mild Cognitive Impairment and Alzheimer Disease. Kamagata K, Andica C, Takabayashi K, Saito Y, Taoka T, Nozaki H, Kikuta J, Fujita S, Hagiwara A, Kamiya K, Wada A, Akashi T, Sano K, Nishizawa M, Hori M, Naganawa S, Aoki S, Alzheimer's Disease Neuroimaging Initiative. Neurology; 2022 Dec 12; 99(24):e2648-e2660. PubMed ID: 36123122 [Abstract] [Full Text] [Related]
15. Cognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric Multiple Sclerosis. Margoni M, Pagani E, Meani A, Preziosa P, Mistri D, Gueye M, Moiola L, Filippi M, Rocca MA. Ann Neurol; 2024 Jun 12; 95(6):1080-1092. PubMed ID: 38481063 [Abstract] [Full Text] [Related]
16. Unveiling the link between glymphatic function and cortical microstructures in post-traumatic stress disorder. Shao Z, Gao X, Cen S, Department of Defense Alzheimer's Disease Neuroimaging Initiative, Tang X, Gong J, Ding W. J Affect Disord; 2024 Nov 15; 365():341-350. PubMed ID: 39178958 [Abstract] [Full Text] [Related]
17. Evaluation of glymphatic system activity using diffusion tensor image analysis along the perivascular space and amyloid PET in older adults with objectively normal cognition: a preliminary study. Park CJ, Kim SY, Kim JH, Son NH, Park JY, Jeong YH, Kim HJ, Park J, Kim WJ. Front Aging Neurosci; 2023 Nov 15; 15():1221667. PubMed ID: 37577357 [Abstract] [Full Text] [Related]
18. Magnetic Resonance Images Implicate That Glymphatic Alterations Mediate Cognitive Dysfunction in Alzheimer Disease. Hsu JL, Wei YC, Toh CH, Hsiao IT, Lin KJ, Yen TC, Liao MF, Ro LS. Ann Neurol; 2023 Jan 15; 93(1):164-174. PubMed ID: 36214568 [Abstract] [Full Text] [Related]
19. Association of Sleep, Neuropsychological Performance, and Gray Matter Volume With Glymphatic Function in Community-Dwelling Older Adults. Siow TY, Toh CH, Hsu JL, Liu GH, Lee SH, Chen NH, Fu CJ, Castillo M, Fang JT. Neurology; 2022 Feb 22; 98(8):e829-e838. PubMed ID: 34906982 [Abstract] [Full Text] [Related]
20. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation. Racine AM, Adluru N, Alexander AL, Christian BT, Okonkwo OC, Oh J, Cleary CA, Birdsill A, Hillmer AT, Murali D, Barnhart TE, Gallagher CL, Carlsson CM, Rowley HA, Dowling NM, Asthana S, Sager MA, Bendlin BB, Johnson SC. Neuroimage Clin; 2014 Feb 22; 4():604-14. PubMed ID: 24936411 [Abstract] [Full Text] [Related] Page: [Next] [New Search]